Dear All:I have just learned of a recently opened grant program from NNF (Novo Nordisk Foundation) that seeks to fund early-stage proof-of-concept on rapid, minimally invasive and affordable testing for LRTIs ((Lower Respiratory Tract Infections) at the point-of-care in global settings. The grant program actually opened just after ESCMID and I missed the announcement ... apologies! It's a substantial funding opportunity ... here are the key details:Website: https://novonordiskfonden.dk/en/grant/challenge-programme-2027-advancing-next-generation-amr-diagnostics-for-lower-respiratory-tract-infections/What type of program is eliglble?"... goal of this programme is to provide a foundation for solutions that enable minimally invasive, direct-from-specimen rapid diagnosis of LRTIs""Projects which are mainly focused on surveillance, establishment/maintaining infrastructure, and clinical trial(s) will not be considered"Creativity is encouraged: The RFP mentions ideas such as technologic advancement (e.g., microfluidics), use of biomarkers, and data mining to find new correlatesWho is eligible?"... research must be anchored at a research institution or non-profit organisation, and that for-profit product development/optimisation is out of scope for this call.""The main applicant must be an independent tenured/tenure-track researcher with their own research group, employed at a European university, hospital, or non-profit research organisation" Note that European is defined here as European Union, Schengen Area plus the United Kingdom).There can be as many as 4 collaborators...